Draft:Yossi Buganim
 | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by מיכל פידי (talk | contribs) 0 seconds ago. (Update) |
Yosef (Yossi) Buganim (born March 5, 1977) is an Israeli scientist, professor, and entrepreneur specializing in stem cell biology, nuclear reprogramming, and regenerative medicine. Buganim is an international HHMI (Howard Hughes Medical Institute) scholar and is renowned for his pioneering research in cellular reprogramming, transdifferentiating, and epigenetics, contributing significantly to the understanding of cell fate acquisition and advancing the fields of developmental biology and regenerative medicine.
Early Life and Education
[edit]Buganim completed his B.Sc. and M.Sc. in life sciences at Bar-Ilan University, graduating with distinction. His M.Sc. research concentrated on developmental biology, utilizing the Drosophila Melanogaster model as a powerful tool to investigate fundamental developmental processes. He pursued his Ph.D. at the Weizmann Institute of Science under the guidance of Prof. Varda Rotter, investigating tumor suppressor activity and the interplay between p53 and oncogenic Ras. During this time, Buganim made critical discoveries about cancer mechanisms, which were published in leading scientific journals.
Following his Ph.D., Buganim conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT under the mentorship of Prof. Rudolf Jaenisch. There, he explored the molecular mechanisms underlying cellular reprogramming to pluripotency.
Academic and Research Career
[edit]In 2014, Buganim joined the Hebrew University of Jerusalem as a faculty member in the Department of Developmental Biology and Cancer Research. Since then, he has led groundbreaking research in stem cell biology and regenerative medicine.
Key Research Contributions
[edit]Cellular Reprogramming and Direct Lineage Conversion:
[edit]- Revealed late hierarchical phases in reprogramming, highlighting the pivotal role of SOX2 in initiating the late deterministic stage of the reprogramming process.